Ticker Details
Ironwood Pharmaceuticals, Inc. Ironwood Pharmaceuticals Inc is a biotechnology company which is focused on advancing innovative product opportunities in areas of large unmet needs such as constipation, gastrointestinal disorders, hyperuricemia, among others.
IPO Date:	February 3, 2010
Sector:	Healthcare
Industry:	Drug Manufacturers
Market Cap:	$541.58M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.24 | 2.42%
Avg Daily Range (30 D):	$0.16 | 4.01%
Avg Daily Range (90 D):	$0.17 | 4.41%

Institutional Daily Volume
Avg Daily Volume:	1.33M
Avg Daily Volume (30 D):	2.17M
Avg Daily Volume (90 D):	2.21M

Trade Size
Avg Trade Size (Sh.):	140
Avg Trade Size (Sh.) (30 D):	135
Avg Trade Size (Sh.) (90 D):	144

Institutional Trades
Total Institutional Trades:	7,675
Avg Institutional Trade:	$1.92M
Avg Institutional Trade (30 D):	$1.07M
Avg Institutional Trade (90 D):	$1.69M
Avg Institutional Trade Volume:	.18M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$2.53M
Avg Closing Trade (30 D):	$1.03M
Avg Closing Trade (90 D):	$1.29M
Avg Closing Volume:	255.91K

News

Feb 9, 2026 @ 6:55 PM 3 Stocks Trading Near $5 With Massive Earnings Ups... Source: Chris Markoch

Jan 5, 2026 @ 1:36 PM Stock Market Today: S&P 500, Nasdaq, WTI Crude Fut... Source: Rishabh Mishra

Jan 2, 2026 @ 6:30 PM Ironwood Finds a New Floor as LINZESS Net Pricing ... Source: Timothy Fries

Apr 14, 2025 @ 6:19 PM Ironwood Pharmaceuticals Stock Plunges, FDA Wants ... Source: Vandana Singh

Dec 6, 2024 @ 12:00 PM Beam Therapeutics Announces Appointment of Sravan ... Source: N/A

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$.64	$.25	$-.01
Diluted EPS	$.6	$.24	$-.01
Revenue	$361.51M	$106.51M	$47.71M
Gross Profit
Net Income / Loss	$102.18M	$40.77M	$-2.28M
Operating Income / Loss	$200.18M	$72.57M	$6.81M
Cost of Revenue
Net Cash Flow	$112.42M	$5.12M	$74.7M
PE Ratio